Oncogenesis and poliomyelitis vaccine.
D001315:Australia; D001500:BCG Vaccine / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D022121:Cholera Vaccines / Q000009:adverse effects; D004165:Diphtheria / Q000517:prevention & control; D005500:Follow-Up Studies; D006801:Humans; D007114:Immunization; D007223:Infant; D007231:Infant, Newborn; D007938:Leukemia / Q000401:mortality; D009369:Neoplasms / Q000139:chemically induced*; D011051:Poliomyelitis / Q000517:prevention & control; D017955:Poliovirus / Q000472:pathogenicity*; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects*; D013539:Simian virus 40 / Q000472:pathogenicity; D012900:Smallpox Vaccine / Q000009:adverse effects; D013742:Tetanus / Q000517:prevention & control; D014436:Typhoid-Paratyphoid Vaccines / Q000009:adverse effects; D014917:Whooping Cough / Q000517:prevention & control
D001500:BCG Vaccine; D022121:Cholera Vaccines; D011054:Poliovirus Vaccine, Inactivated; D012900:Smallpox Vaccine; D014436:Typhoid-Paratyphoid Vaccines